| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/10/2008 | CA2673924A1 Liposomal pharmaceutical preparation and method for manufacturing the same |
| 07/10/2008 | CA2673870A1 Compositions and methods for the treatment of infections and tumors |
| 07/10/2008 | CA2673868A1 Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo |
| 07/10/2008 | CA2673752A1 Compositions and methods for stimulating an immune response |
| 07/10/2008 | CA2673428A1 Tetrahydrobenzoisoxazole and tetrahydroindazole derivatives as modulators of the mitotic motor protein |
| 07/10/2008 | CA2673232A1 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature |
| 07/10/2008 | CA2672933A1 Method of treating cancer by a combined therapy of anticancer agents |
| 07/10/2008 | CA2670658A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 07/10/2008 | CA2668738A1 Novel aminopyrimidine derivatives as plk1 inhibitors |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942113A1 Neuronal differentiation inhibitor peptide and use thereof |
| 07/09/2008 | EP1942109A1 Taxane compound with azetidine ring structure |
| 07/09/2008 | EP1942108A1 Compound containing basic group and use thereof |
| 07/09/2008 | EP1942093A1 Novel cyclohexenone compounds from antrodia camphorata and application thereof |
| 07/09/2008 | EP1941909A1 Preventives/remedies for cancer |
| 07/09/2008 | EP1941906A1 Hepatic fibrosis inhibitor |
| 07/09/2008 | EP1941905A1 APO-2 Ligand-anti-her-2 antibody synergism |
| 07/09/2008 | EP1941890A1 Hematopoietic stem cell proliferator |
| 07/09/2008 | EP1941887A1 Metallo-fullerenols and its application in preparation of medicines for inhibiting the growth of tumour |
| 07/09/2008 | EP1941871A1 Formulations for prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| 07/09/2008 | EP1941829A2 Noninvasive measurement of chemical substances |
| 07/09/2008 | EP1941038A2 snRNA GENE-LIKE TRANSCRIPTIONAL UNITS AND USES THEREOF |
| 07/09/2008 | EP1940881A2 Compositions comprising cross-species-specific antibodies and uses thereof |
| 07/09/2008 | EP1940870A2 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 07/09/2008 | EP1940848A1 Antimitotic rhizoxin derivatives of burkholderia rhizoxina, method for producing said derivatives and use thereof |
| 07/09/2008 | EP1940847A2 Pyrazolopyrimidines as protein kinase inhibitors |
| 07/09/2008 | EP1940846A2 Pyrimidin-4-yl-3,4-dihydro-2h-pyrrolo[1,2a]pyrazin-1-one compounds |
| 07/09/2008 | EP1940844A2 Compounds and compositions as protein kinase inhibitors |
| 07/09/2008 | EP1940843A2 Unsaturated heterocyclic derivatives |
| 07/09/2008 | EP1940840A1 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof |
| 07/09/2008 | EP1940839A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kalpha |
| 07/09/2008 | EP1940825A1 Quinazoline derivatives as anticancer agents |
| 07/09/2008 | EP1940796A1 Isoquinolines derivatives as igf-1r inhibitors |
| 07/09/2008 | EP1940794A2 Quinoline derivatives and use as antitumor agents |
| 07/09/2008 | EP1940787A1 Novel ido inhibitors and methods of use thereof |
| 07/09/2008 | EP1940773A2 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors |
| 07/09/2008 | EP1940453A2 Therapeutic combination of hamlet and a hdac inhibitor to treat cancer |
| 07/09/2008 | EP1940430A2 Listeria-induced immunorecruitment and activation, and methods of use thereof |
| 07/09/2008 | EP1940415A1 19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3 |
| 07/09/2008 | EP1940410A1 Regimen of administration for 5-(2-chlorophenyl)-1 ,2-dihydro-7-fluoro-8-methoxy-3-methyl-pyrazolo [3, 4.-b] [1, 4] benzodiazepine |
| 07/09/2008 | EP1940407A2 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators |
| 07/09/2008 | EP1940386A2 Wortmannin conjugates and uses thereof |
| 07/09/2008 | EP1841316A4 Regulation of ccn2 by ccn3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases |
| 07/09/2008 | EP1768978B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 07/09/2008 | EP1753512B1 Tetrahydropyridothiophenes |
| 07/09/2008 | EP1687305B1 1h-imidazoquinoline derivatives as protein kinase inhibitors |
| 07/09/2008 | EP1684747B1 Bisindolyl maleimides useful for treating prostate cancer and akt-mediated diseases |
| 07/09/2008 | EP1653957B1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 07/09/2008 | EP1534289B1 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 07/09/2008 | EP1474396B9 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 07/09/2008 | EP1469858B1 Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 07/09/2008 | EP1427391B1 Solid-phase agent for vascular occlusion with immobilised platelet binding agent |
| 07/09/2008 | EP1379251B1 Inhibitors of akt activity |
| 07/09/2008 | EP1286674B1 Composition for potentiating cancer chemotherapeutic agents |
| 07/09/2008 | EP1276729B1 New neurokinin antagonists for use as medicaments |
| 07/09/2008 | EP1234185B1 Pin1 as a marker of the stage of agressiveness and/or metastasis of abnormal cell growth |
| 07/09/2008 | EP1234041B1 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 07/09/2008 | EP1226177B1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 07/09/2008 | EP1156813B1 Reovirus for the treatment of cellular proliferative disorders |
| 07/09/2008 | CN101218257A GITR binding molecules and uses therefor |
| 07/09/2008 | CN101218256A Antibodies against cd38 for treatment of multiple myeloma |
| 07/09/2008 | CN101218241A Pyrrolopyridine derivatives as protein kinase inhibitors |
| 07/09/2008 | CN101218238A Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 07/09/2008 | CN101218229A Pyrazolyl-amino-substituted pyrimidines and their use in the treatment of cancer |
| 07/09/2008 | CN101218211A Quinoxaline derivatives as antitumor agents |
| 07/09/2008 | CN101218204A Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors |
| 07/09/2008 | CN101217971A Treatment of tumors |
| 07/09/2008 | CN101217967A Novel use of enantiomer |
| 07/09/2008 | CN101217966A Combination therapy of cancer with AZD2171 and gemcitabine |
| 07/09/2008 | CN101217954A Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 07/09/2008 | CN101217953A Compounds having immunomodulator activity |
| 07/09/2008 | CN101217946A Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy |
| 07/09/2008 | CN101215563A KDR siRNA and application thereof |
| 07/09/2008 | CN101215561A MiR-181a antisense oligonucleotide with leukemia resisting action and application thereof |
| 07/09/2008 | CN101215560A MiR-21 antisense oligonucleotide with leukemia resisting action and application thereof |
| 07/09/2008 | CN101215332A CRIPTO blocking antibodies and uses thereof |
| 07/09/2008 | CN101215328A Antineoplastic activity protein in syngnathus acus linnaeus |
| 07/09/2008 | CN101215327A Pumpkin protein and coding gene thereof |
| 07/09/2008 | CN101215326A Luffa acutangula protein 1 and coding gene thereof |
| 07/09/2008 | CN101215317A Method for preparing syngnathus acus linnaeus antineoplastic activity protein |
| 07/09/2008 | CN101215313A Marsdenia tenacissima carbon-21 steroid saponin mixture with antineoplastic effect |
| 07/09/2008 | CN101215305A Glucosyl thiourea heterocyclic compound and its synthetic method and application in antineoplastic |
| 07/09/2008 | CN101215304A Lactosyl thiourea heterocyclic compound and its synthetic method and application in antineoplastic |
| 07/09/2008 | CN101215303A Xylosyl thiourea heterocyclic compound and its synthetic method and application in antineoplastic |
| 07/09/2008 | CN101215286A Tricyclic androgen receptor modulator compounds and methods |
| 07/09/2008 | CN101215281A Isoflavone sulfonate derivatives and synthetic method thereof |
| 07/09/2008 | CN101215280A Leukemia-resisting isoflavone sulfonate derivatives and synthetic method thereof |
| 07/09/2008 | CN101215279A Dyestuff lignin sulfonic acid ester derivatices and preparation method thereof |
| 07/09/2008 | CN101215277A Two anti-cancer medicament raw material compounds |
| 07/09/2008 | CN101215276A N,N'-substituted phenylpropylamino acid phenylpropylaminoalcohols esters derivatives and preparation method thereof |
| 07/09/2008 | CN101215259A Pyridines derivatives, pharmacological receivable salt thereof, composition containing the said substances and use thereof |
| 07/09/2008 | CN101214381A Acute promyelocytic leukemia DNA vaccine PML-RAR alpha-hGM-CSF and preparation and application thereof |
| 07/09/2008 | CN101214376A Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 07/09/2008 | CN101214372A Construction method of protein vaccine for in vivo inducing autoantibody aiming at TNF-alpha molecule |
| 07/09/2008 | CN101214371A Application of human recombination protein PDCD5 in preparing tumor chemotherapy sensitizing medicine |
| 07/09/2008 | CN101214370A Polypeptide medicament for treating tumor caused by human papillomavirus type 16 or vaccine |
| 07/09/2008 | CN101214369A Polypeptide medicament for treating tumor caused by human papillomavirus type 18 or vaccine |
| 07/09/2008 | CN101214364A Chinese medicine preparation for treating esophagus cancer and stomach cancer |
| 07/09/2008 | CN101214361A Formula of ointment and preparation thereof |
| 07/09/2008 | CN101214331A Pharmaceutical composition for treating leukemia and cancer |